Table I.
Select vaccines containing polysorbate excipients
Polysorbate | Vaccine name | Vaccine type | Total mg per dose |
---|---|---|---|
Polysorbate 20 | Havrix (adult) | HepA | 0.050 |
Polysorbate 20 | Flublok | Influenza | 0.028 |
Polysorbate 20 | Flublok Quad | Influenza | 0.028 |
Polysorbate 20 | Havrix (child) | HepA | 0.025 |
Polysorbate 20 | Sanofi∗ | SARS-CoV-2† | Unknown |
Polysorbate 20 | Twinrix | HepA + HepB | Not specified |
Polysorbate 80 | Flucelvax Quad | Influenza | ≤1.50 |
Polysorbate 80 | Fluad | Influenza | 1.18 |
Polysorbate 80 | Flulaval Quad | Influenza | ≤0.887 |
Polysorbate 80 | Fluarix Quad | Influenza | ≤0.55 |
Polysorbate 80 | Jansen COVID-19 | SARS-CoV-2 | 0.16 |
Polysorbate 80 | Boostrix | Tdap | ≤0.10 |
Polysorbate 80 | Infanrix | DTaP | ≤0.10 |
Polysorbate 80 | Kinrix | DTaP + IPV | ≤0.10 |
Polysorbate 80 | Pediarix | DTaP + HepB + IPV | ≤0.10 |
Polysorbate 80 | Prevnar 13 | Pneumococcal 13-valent | ≤0.10 |
Polysorbate 80 | Shingrix | Zoster | 0.080 |
Polysorbate 80 | Gardasil | HPV | 0.050 |
Polysorbate 80 | Gardasil 9 | HPV | 0.050 |
Polysorbate 80 | Heplisav-B | HepB | 0.050 |
Polysorbate 80 | Vaxelis | Dtap-IPV-Hib-HepB | ≤0.030 |
Polysorbate 80 | Trumenba | Meningococcal Group B | 0.018 |
Polysorbate 80 Polysorbate 80 |
AstraZeneca Sanofi∗ |
SARS-CoV-2† SARS-CoV-2†AS03 adjuvant |
≤0.007 mg 4.86 mg |
Polysorbate 80 | JE-Vax | Japanese encephalitis | ≤0.0074 |
Polysorbate 80 | Pentacel | DTaP + IPV + Hib | 0.0050 |
Polysorbate 80 | Quadracel | DTaP + IPV | 0.0050 |
Polysorbate 80 | RotaTeq | Rotavirus | Not specified |
SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2.
The SARS-CoV-2 Sanofi vaccine contains polysorbate 20 (unknown mg/dose) with polysorbate 80 in the AS03 adjuvant (4.86 mg/dose).
Not approved by the Food and Drug Administration.